CLINICAL TRIALS PROFILE FOR ALPROLIX

All Clinical Trials for ALPROLIX

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00716716 ↗	Phase I/IIa Study of FIXFc in Hemophilia B Patients	Completed	Swedish Orphan Biovitrum	Phase 1	2008-04-01	The primary objective of the study is to assess safety of FIXFc at doses ranging from 1 to 100 IU/kg.
NCT00716716 ↗	Phase I/IIa Study of FIXFc in Hemophilia B Patients	Completed	Syntonix Pharmaceuticals, Inc.	Phase 1	2008-04-01	The primary objective of the study is to assess safety of FIXFc at doses ranging from 1 to 100 IU/kg.
NCT00716716 ↗	Phase I/IIa Study of FIXFc in Hemophilia B Patients	Completed	Biogen	Phase 1	2008-04-01	The primary objective of the study is to assess safety of FIXFc at doses ranging from 1 to 100 IU/kg.
NCT00716716 ↗	Phase I/IIa Study of FIXFc in Hemophilia B Patients	Completed	Bioverativ Therapeutics Inc.	Phase 1	2008-04-01	The primary objective of the study is to assess safety of FIXFc at doses ranging from 1 to 100 IU/kg.
NCT02392156 ↗	Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes	Terminated	Swedish Orphan Biovitrum		2015-07-01	The primary objective of the study is to evaluate the effectiveness of prophylactic treatment with recombinant Factor VIII Fc fusion protein (rFVIIIFc) and recombinant Factor IX Fc fusion protein (rFIXFc) therapy as assessed by patient treatment burden and health economic outcomes while maintaining disease control in males with hemophilia A or B.

Clinical Trial Conditions for ALPROLIX

Condition Name

Condition Name for ALPROLIX
Intervention	Trials
Hemophilia B	2
Haemophilia B	1
Hemophilia	1
Hemophilia A	1

Condition MeSH

Condition MeSH for ALPROLIX
Intervention	Trials
Hemophilia A	4
Hemophilia B	3
Menorrhagia	1
Hemostatic Disorders	1

Clinical Trial Locations for ALPROLIX

Trials by Country

Trials by Country for ALPROLIX
Location	Trials
United States	15
Switzerland	1
Germany	1

Trials by US State

Trials by US State for ALPROLIX
Location	Trials
Michigan	2
Pennsylvania	2
Illinois	2
Georgia	1
Oklahoma	1

Clinical Trial Progress for ALPROLIX

Clinical Trial Phase

Clinical Trial Phase for ALPROLIX
Clinical Trial Phase	Trials
Phase 1	2
Early Phase 1	1

Clinical Trial Status

Clinical Trial Status for ALPROLIX
Clinical Trial Phase	Trials
Completed	3
Terminated	1

Clinical Trial Sponsors for ALPROLIX

Sponsor Name

Sponsor Name for ALPROLIX
Sponsor	Trials
Bioverativ Therapeutics Inc.	3
Swedish Orphan Biovitrum	2
Biogen	2

Sponsor Type

Sponsor Type for ALPROLIX
Sponsor	Trials
Industry	9
Other	1